Ausgabe 12/2022
Inhalt (11 Artikel)
Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study
Alexander Fabian, Justus Domschikowski, Wolfgang Greiner, Gunnar Bockelmann, Elias Karsten, Alexander Rühle, Nils H. Nicolay, Anca L. Grosu, Jürgen Dunst, David Krug
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
Christoph Schiffner, Hans Christiansen, Iris Brandes, Gerrit Grannas, Jörn Wichmann, Roland Merten
Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome
Manuel Guhlich, Teresa Esther Maag, Leif Hendrik Dröge, Rami A. El Shafie, Andrea Hille, Sandra Donath, Markus Anton Schirmer, Olga Knaus, Friedemann Nauck, Tobias Raphael Overbeck, Marc Hinterthaner, Wolfgang Körber, Stefan Andreas, Achim Rittmeyer, Martin Leu, Stefan Rieken
Primary lesion radiotherapy during first-line icotinib treatment in EGFR-mutated NSCLC patients with multiple metastases and no brain metastases: a single-center retrospective study
Rui Deng, Jinkun Liu, Tongjun Song, Tao Xu, Yong Li, Long Duo, Longchao Xiang, Xiongjie Yu, Jinhua Lei, Fengjun Cao
Serum lactate dehydrogenase predicts brain metastasis and survival in limited-stage small cell lung cancer patients treated with thoracic radiotherapy and prophylactic cranial irradiation
Jianjiang Liu, Dongping Wu, Bin Shen, Mengyuan Chen, Xia Zhou, Peng Zhang, Guoqin Qiu, Yongling Ji, Xianghui Du, Yang Yang
Focal cavity radiotherapy after neurosurgical resection of brain metastases: sparing neurotoxicity without compromising locoregional control
Klaus-Henning Kahl, Ehab Shiban, Susanne Gutser, Christoph J. Maurer, Björn Sommer, Heiko Müller, Ina Konietzko, Ute Grossert, Ansgar Berlis, Tilman Janzen, Georg Stüben
Obituary for Herman D. Suit, M.D., D. Phil.
Michael Baumann, Wilfried Budach, Jürgen Debus
Zur Erinnerung an Prof. Dr. med. Manfred Strietzel
Thomas Herrmann, Johannes Schorcht, Guido Hildebrandt
Eine Monotherapie mit Immuncheckpointblockade führt bei Patienten mit Rektumkarzinom und Mikrosatelliteninstabilität zur klinischen Komplettremission
Markus Diefenhardt, Emmanouil Fokas, Claus Rödel
Salvage-Bestrahlung der Prostataloge: Mitbestrahlung der regionalen LK und Bedeutung der ADT
Felix Grabenbauer, Michael Flentje
Boost und Hypofraktionierung beim DCIS
Jürgen Dunst, David Krug